February 13, 2020 -- Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry (LC-MS).
The partnership will utilize Thermo Fisher's LC-MS technology and NanoPin's diagnostic platform to identify disease-related antigens from patient blood samples. The goal is that the companies' combined technologies will lead to the development of clinical assays for infectious diseases, ultimately reducing time to results.